Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
30,146,471
-
Share change
-
+1,291,590
-
Total reported value
-
$3,519,028,040
-
Put/Call ratio
-
90%
-
Price per share
-
$116.75
-
Number of holders
-
194
-
Value change
-
-$43,624,585
-
Number of buys
-
121
-
Number of sells
-
107
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2015
As of 30 Jun 2015,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
194 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,146,471 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Grantham, Mayo, Van Otterloo & Co. LLC, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, and Capital International Investors.
This page lists
191
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.